Regulating the Liabilities of Agricultural BiotechnologyStuart Smyth This book examines how government, industry and society interact to reach a level of regulation that is deemed satisfactory for the newly-emerged transformative technology that is agricultural biotechnology. It considers issues of risk and trust surrounding genetically-modified plants for the production of food and pharmaceuticals. It describes how regulations have been produced to manage, or in some cases ignore, the risks from GM products. The scope is international and the book makes a significant contribution to the literature in this growing field of interest. |
Contents
2 | 19 |
4 | 27 |
Consumer Responses to GM Foods | 43 |
10 | 49 |
Regulating Transformative Technologies | 59 |
International Governance of Liabilities | 77 |
Common terms and phrases
adoption agri-food agricultural biotechnology approved Aventis benefits Canada Canadian canola CanAmera canola challenge Chapter co-mingling commercial commercialisation companies concerns consumers consumption contracts costs countries create crop varieties cross-pollination damage domestic economic effective ensure environmental erucic acid estimated export field trials food safety gene flow genetically modified global GM crops GM food products GM foods GM products grains and oilseeds growers HT canola identified identity preservation impacts important industry innovation institutions involved IPPM systems issue maize manage mandatory labelling market failure marketplace Monsanto non-GM organisations output traits pharmaceutical plant-made pharmaceuticals PMPs pollen potential precautionary principle premium private firms product differentiation systems purchase GM regulators regulatory systems result risk analysis risk assessment role Saskatchewan Wheat Pool scientific scientists sector segregation system socio-economic liabilities soybeans standards StarLink supply chain Table tolerance levels traceability systems trade transaction transformative technology transgenic crops